For: | Kang HS, Koo JS, Lee KM, Kim DB, Lee JM, Kim YJ, Yoon H, Jang HJ. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use. World J Gastroenterol 2019; 25(8): 989-1001 [PMID: PMC6397722 DOI: 10.3748/wjg.v25.i8.989] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i8/989.htm |
Number | Citing Articles |
1 |
Marcus Bauer, Loant Baholli, Lutz Uflacker, Sven Rolffs. Perimyokarditis als Komplikation einer medikamentösen Mehrfachtherapie bei Colitis ulcerosa. DMW - Deutsche Medizinische Wochenschrift 2022; 147(16): 1055 doi: 10.1055/a-1894-4615
|
2 |
Yingbo Han, Xiumin Liu, Hongmei Dong, Dacheng Wen. Screening of characteristic genes in ulcerative colitis by integrating gene expression profiles. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01940-0
|
3 |
Amanda Ricciuto, David R Mack, Hien Q Huynh, Kevan Jacobson, Anthony R Otley, Jennifer deBruyn, Wael El-Matary, Colette Deslandres, Mary E Sherlock, Jeffrey N Critch, Kevin Bax, Prevost Jantchou, Ernest G Seidman, Nicholas Carman, Mohsin Rashid, Aleixo Muise, Eytan Wine, Matthew W Carroll, Sally Lawrence, Johan Van Limbergen, Eric I Benchimol, Thomas D Walters, Anne M Griffiths, Peter C Church. Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn’s Disease. Journal of Crohn's and Colitis 2021; 15(3): 419 doi: 10.1093/ecco-jcc/jjaa197
|
4 |
Jesús K. Yamamoto-Furusho, Norma N. Parra-Holguín. Diagnostic Delay of Inflammatory Bowel Disease Is Significantly Higher in Public versus Private Health Care System in Mexican Patients. Inflammatory Intestinal Diseases 2022; 7(2): 72 doi: 10.1159/000520522
|
5 |
Chen Chen, Yue Su, Shihang Li, Chaoxin Man, Yujun Jiang, Bo Qu, Xinyan Yang, Ling Guo. Advances in oligosaccharides and polysaccharides with different structures as wall materials for probiotics delivery: A review. International Journal of Biological Macromolecules 2024; 277: 134468 doi: 10.1016/j.ijbiomac.2024.134468
|
6 |
Eleanor Cross, Benjamin Saunders, Adam D. Farmer, James A. Prior. Diagnostic delay in adult inflammatory bowel disease: A systematic review. Indian Journal of Gastroenterology 2023; 42(1): 40 doi: 10.1007/s12664-022-01303-x
|
7 |
Jiao Yang, M.M. Cai Huang, M.M. Jing-Wen Liang, M.M. Yan-Chang Lei. The diagnostic performance of serum αvβ6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(4): 102317 doi: 10.1016/j.clinre.2024.102317
|
8 |
Kang-Moon Lee. Epidemiology and diagnosis of inflammatory bowel diseases. Journal of the Korean Medical Association 2021; 64(9): 579 doi: 10.5124/jkma.2021.64.9.579
|
9 |
Adam S Faye, Kristine Højgaard Allin, Aske T Iversen, Manasi Agrawal, Jeremiah Faith, Jean-Frederic Colombel, Tine Jess. Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study. Gut 2023; 72(4): 663 doi: 10.1136/gutjnl-2022-327845
|
10 |
Swapna Mahurkar‐Joshi, Mike Thompson, Elizza Villarruel, James D. Lewis, Lisa D. Lin, Mary Farid, Hamed Nayeb‐Hashemi, Tina Storage, Guy A. Weiss, Berkeley N. Limketkai, Jenny S. Sauk, Emeran A. Mayer, Lin Chang. Genome‐Wide DNA Methylation Identifies Potential Disease‐Specific Biomarkers and Pathophysiologic Mechanisms in Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Celiac Disease. Neurogastroenterology & Motility 2025; 37(2) doi: 10.1111/nmo.14980
|
11 |
Nishani Jayasooriya, Sonia Saxena, Jonathan Blackwell, Alex Bottle, Hanna Creese, Irene Petersen, Richard C G Pollok. Associations between prior healthcare use, time to diagnosis, and clinical outcomes in inflammatory bowel disease: a nationally representative population-based cohort study. BMJ Open Gastroenterology 2024; 11(1): e001371 doi: 10.1136/bmjgast-2024-001371
|
12 |
Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C. Pollok. Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2023; 57(6): 635 doi: 10.1111/apt.17370
|